High Tech Pharm Statistics

Total Valuation

High Tech Pharm has a market cap or net worth of KRW 205.33 billion. The enterprise value is 190.93 billion.

Market Cap	205.33B
Enterprise Value	190.93B

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	Dec 29, 2025

Share Statistics

High Tech Pharm has 10.63 million shares outstanding.

Current Share Class	10.63M
Shares Outstanding	10.63M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.77%
Owned by Institutions (%)	0.25%
Float	5.81M

Valuation Ratios

The trailing PE ratio is 17.89.

PE Ratio	17.89
Forward PE	n/a
PS Ratio	2.93
PB Ratio	1.57
P/TBV Ratio	1.57
P/FCF Ratio	13.60
P/OCF Ratio	12.06
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.45, with an EV/FCF ratio of 12.64.

EV / Earnings	16.64
EV / Sales	2.72
EV / EBITDA	10.45
EV / EBIT	14.85
EV / FCF	12.64

Financial Position

The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.00.

Current Ratio	5.67
Quick Ratio	2.06
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.00
Interest Coverage	71.36

Financial Efficiency

Return on equity (ROE) is 9.17% and return on invested capital (ROIC) is 9.26%.

Return on Equity (ROE)	9.17%
Return on Assets (ROA)	5.66%
Return on Invested Capital (ROIC)	9.26%
Return on Capital Employed (ROCE)	9.80%
Weighted Average Cost of Capital (WACC)	5.37%
Revenue Per Employee	1.08B
Profits Per Employee	176.54M
Employee Count	65
Asset Turnover	0.49
Inventory Turnover	1.36

Taxes

In the past 12 months, High Tech Pharm has paid 2.35 billion in taxes.

Income Tax	2.35B
Effective Tax Rate	17.01%

Stock Price Statistics

The stock price has increased by +46.73% in the last 52 weeks. The beta is 0.19, so High Tech Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+46.73%
50-Day Moving Average	18,284.20
200-Day Moving Average	13,938.00
Relative Strength Index (RSI)	49.07
Average Volume (20 Days)	84,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, High Tech Pharm had revenue of KRW 70.18 billion and earned 11.48 billion in profits.

Revenue	70.18B
Gross Profit	16.94B
Operating Income	12.86B
Pretax Income	13.83B
Net Income	11.48B
EBITDA	18.27B
EBIT	12.86B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 14.43 billion in cash and 33.61 million in debt, giving a net cash position of 14.40 billion or 1,353.88 per share.

Cash & Cash Equivalents	14.43B
Total Debt	33.61M
Net Cash	14.40B
Net Cash Per Share	1,353.88
Equity (Book Value)	130.67B
Book Value Per Share	n/a
Working Capital	58.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.03 billion and capital expenditures -1.93 billion, giving a free cash flow of 15.10 billion.

Operating Cash Flow	17.03B
Capital Expenditures	-1.93B
Depreciation & Amortization	5.42B
Net Borrowing	-7.97B
Free Cash Flow	15.10B
FCF Per Share	1,420.24

Full Cash Flow Statement

Margins

Gross margin is 24.13%, with operating and profit margins of 18.32% and 16.35%.

Gross Margin	24.13%
Operating Margin	18.32%
Pretax Margin	19.70%
Profit Margin	16.35%
EBITDA Margin	26.04%
EBIT Margin	18.32%
FCF Margin	21.52%

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 0.76%.

Dividend Per Share	150.00
Dividend Yield	0.76%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	1
Payout Ratio	9.27%
Buyback Yield	n/a
Shareholder Yield	0.76%
Earnings Yield	5.59%
FCF Yield	7.35%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

High Tech Pharm has an Altman Z-Score of 8.77 and a Piotroski F-Score of 5.

Altman Z-Score	8.77
Piotroski F-Score	5